The store will not work correctly when cookies are disabled.
3,5-dichloro-N-[3-chloro-4-(3-hydroxyphenoxy)phenyl]-2-hydroxy-benzamide
ID: ALA4762871
PubChem CID: 162660159
Max Phase: Preclinical
Molecular Formula: C19H12Cl3NO4
Molecular Weight: 424.67
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1ccc(Oc2cccc(O)c2)c(Cl)c1)c1cc(Cl)cc(Cl)c1O
Standard InChI: InChI=1S/C19H12Cl3NO4/c20-10-6-14(18(25)16(22)7-10)19(26)23-11-4-5-17(15(21)8-11)27-13-3-1-2-12(24)9-13/h1-9,24-25H,(H,23,26)
Standard InChI Key: IGKPTXCWCUVUSI-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
26.7205 -19.6791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7212 -20.5023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4339 -20.9134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1422 -20.4985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1374 -19.6722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4283 -19.2689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8556 -20.9085 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.5658 -20.4930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2764 -20.9074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9862 -20.4926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9835 -19.6704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2651 -19.2648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5582 -19.6778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2768 -21.7287 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
31.6931 -19.2581 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.4071 -19.6630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1168 -19.2508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4114 -20.4843 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.8251 -19.6578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5343 -19.2462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5304 -18.4240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8115 -18.0152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1094 -18.4333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3938 -18.0270 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.8044 -17.1939 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
35.2480 -19.6515 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
26.0138 -20.9113 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
9 14 1 0
11 15 1 0
15 16 1 0
16 17 1 0
16 18 2 0
17 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 17 1 0
23 24 1 0
22 25 1 0
20 26 1 0
2 27 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 424.67 | Molecular Weight (Monoisotopic): 422.9832 | AlogP: 6.10 | #Rotatable Bonds: 4 |
Polar Surface Area: 78.79 | Molecular Species: ACID | HBA: 4 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 5.95 | CX Basic pKa: ┄ | CX LogP: 5.77 | CX LogD: 4.40 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.47 | Np Likeness Score: -0.98 |
References
1. Fujii S,Kikuchi E,Watanabe Y,Suzuyama H,Ishigami-Yuasa M,Mori T,Isobe K,Uchida S,Kagechika H. (2020) Structural development of N-(4-phenoxyphenyl)benzamide derivatives as novel SPAK inhibitors blocking WNK kinase signaling., 30 (17): [PMID:32738993] [10.1016/j.bmcl.2020.127408] |